source
- Dementia finally shows a viable business model, AAIC2026 highlights economic shiftAt the Alzheimer’s Association International Conference in London this year, the author observed that dementia now appears to have a clear business model, a shift from earlier meetings where commer…
- Biotech firms rush to develop gene-editing cure for rare alpha-1 antitrypsin deficiencyA wave of biotech companies is intensifying efforts to cure alpha-1 antitrypsin deficiency (AATD), a rare liver and lung disorder, using gene-editing approaches. Companies such as Beam, Wave Life…